ASO Author Reflections: Are Tumor-Infiltrating Neutrophils Drivers of Metastatic Disease in Esophageal Cancer Patients Treated with Neoadjuvant Therapy?
Ann Surg Oncol
.
2023 Mar;30(3):1626-1627.
doi: 10.1245/s10434-022-12578-x.
Epub 2022 Sep 29.
Authors
Carlos S Cabalag
1
2
3
,
Wayne A Phillips
4
5
6
,
Cuong P Duong
7
5
,
Nicholas J Clemons
8
9
Affiliations
1
Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[email protected]
.
2
Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[email protected]
.
3
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
[email protected]
.
4
Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
5
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
6
Department of Surgery (St. Vincent's Hospital), University of Melbourne, Fitzroy, VIC, Australia.
7
Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
8
Cancer Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
[email protected]
.
9
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
[email protected]
.
PMID:
36175712
PMCID:
PMC9908652
DOI:
10.1245/s10434-022-12578-x
No abstract available
Publication types
Comment
MeSH terms
Esophageal Neoplasms* / therapy
Humans
Neoadjuvant Therapy
Neoplasms, Second Primary*
Neutrophils
Grants and funding
2019/Alan and Kate Gibson Research Fellowship